{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:22:35Z","timestamp":1781644955131,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.arcmed.2011.09.001","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T03:12:39Z","timestamp":1316142759000},"page":"443-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clopidogrel vs. Aspirin Treatment on Admission Improves 5-Year Survival After a First-ever Acute Ischemic Stroke. Data from the Athens Stroke Outcome Project"],"prefix":"10.1016","volume":"42","author":[{"given":"Haralampos J.","family":"Milionis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Gerotziafas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Kostapanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Vemmou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Zis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Spengos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Elisaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos N.","family":"Vemmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2011.09.001_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.arcmed.2011.09.001_bib2","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(99)04407-4","article-title":"Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2011.09.001_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2011.09.001_bib4","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.STR.0000023120.91460.F3","article-title":"Aspirin should be first-line antiplatelet therapy in the secondary prevention of stroke","volume":"33","author":"Warlow","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.arcmed.2011.09.001_bib5","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2011.09.001_bib6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2011.09.001_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2011.09.001_bib8","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/hs1201.100209","article-title":"Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study","volume":"32","author":"Kolominsky-Rabas","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.arcmed.2011.09.001_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000086280","article-title":"The Scandinavian stroke scale predicts outcome in patients with mild ischemic stroke","volume":"20","author":"Christensen","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.arcmed.2011.09.001_bib10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/WNL.50.4.864","article-title":"Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 h) ischemic stroke","volume":"50","author":"Tong","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2011.09.001_bib11","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2011.09.001_bib12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2011.09.001_bib13","first-page":"732","article-title":"European Stroke Initiative: recommendations for stroke management. Organisation of stroke care","volume":"247","author":"Hacke","year":"2000","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.arcmed.2011.09.001_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1474-4422(03)00558-1","article-title":"Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative","volume":"2","author":"Klijn","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcmed.2011.09.001_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.20.8.983","article-title":"Determinants of early recurrence of cerebral infarction. The Stroke Data Bank","volume":"20","author":"Sacco","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.arcmed.2011.09.001_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.60.2.197","article-title":"Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia","volume":"60","author":"Algra","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.arcmed.2011.09.001_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.arcmed.2011.09.001_bib18","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2011.09.001_bib19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2011.09.001_bib20","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin vs. aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2011.09.001_bib21","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole vs. clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2011.09.001_bib22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/STROKEAHA.108.534107","article-title":"Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes","volume":"40","author":"Amarenco","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.arcmed.2011.09.001_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1741-7015-5-29","article-title":"The influence of gender on the effects of aspirin in preventing myocardial infarction","volume":"5","author":"Yerman","year":"2007","journal-title":"BMC Med"},{"issue":"suppl 1","key":"10.1016\/j.arcmed.2011.09.001_bib24","first-page":"S1","article-title":"Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?","volume":"74","author":"Mohler","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.arcmed.2011.09.001_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.beem.2008.12.001","article-title":"Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus","volume":"23","author":"Angiolillo","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440911001949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440911001949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:39:06Z","timestamp":1759261146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440911001949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0188440911001949"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2011.09.001","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clopidogrel vs. Aspirin Treatment on Admission Improves 5-Year Survival After a First-ever Acute Ischemic Stroke. Data from the Athens Stroke Outcome Project","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2011.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}